Insider filing report for Changes in Beneficial Ownership
- Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
- Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
CUSIP No. 60877T 10 1 Page 1 of 5 Pages
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
(Rule 13d-102)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULES 13d-1(b),(c) AND (d) AND AMENDMENTS THERETO FILED
PURSUANT TO RULE 13d-2(b)
(Amendment No. 2)[1]
Momenta Pharmaceuticals, Inc.
- --------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, $.0001 par value
- --------------------------------------------------------------------------------
(Title of Class of Securities)
60877T 10 1
- --------------------------------------------------------------------------------
(CUSIP Number)
December 31, 2006
- --------------------------------------------------------------------------------
Date of Event Which Requires Filing of this Statement
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
[ ] Rule 13d-1(b)
[ ] Rule 13d-1(c)
[ X ] Rule 13d-1(d)
- ---------------------------------------
(1) The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would
alter disclosures provided in a prior cover page. The information required on
the remainder of this cover page shall not be deemed to be "filed" for the
purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise
subject to the liabilities of that section of the Act but shall be subject to
all other provisions of the Act.
CUSIP No. 60877T 10 1 Page 2 of 5 Pages
- --------------------------------------------------------------------------------
1) Name of Reporting Person MVM International Life
I.R.S. Identification Sciences Fund No. 1, L.P.
No. of Above Person
(Entities Only)
- --------------------------------------------------------------------------------
2) Check the Appropriate Box (a) [ X ]
if a Member of a Group (b) [ ]
- --------------------------------------------------------------------------------
3) SEC Use Only
- --------------------------------------------------------------------------------
4) Citizenship or Place United Kingdom
of Organization
- --------------------------------------------------------------------------------
Number of 5) Sole Voting -0-
Shares Beneficially Power
Owned by Each
Reporting Person
With -------------------------------------------------
6) Shared Voting 1,369,696 shares
Power of Common Stock
-------------------------------------------------
7) Sole Disposi- -0-
tive Power
-------------------------------------------------
8) Shared Dis- 1,369,696 shares
positive Power of Common Stock
-------------------------------------------------
9) Aggregate Amount Beneficially 1,369,696 shares
Owned by Each Reporting person of Common Stock
- --------------------------------------------------------------------------------
10) Check if the Aggregate
Amount in Row (9)
Excludes Certain Shares
- --------------------------------------------------------------------------------
11) Percent of Class
Represented by 3.8%
Amount in Row (9)
- --------------------------------------------------------------------------------
12) Type of Reporting Person PN
CUSIP No. 60877T 10 1 Page 3 of 5 Pages
- --------------------------------------------------------------------------------
1) Name of Reporting Person MVM Life Science
I.R.S. Identification Partners L.P.
No. of Above Person
(Entities Only)
- --------------------------------------------------------------------------------
2) Check the Appropriate Box (a) [ X ]
if a Member of a Group (b) [ ]
- --------------------------------------------------------------------------------
3) SEC Use Only
- --------------------------------------------------------------------------------
4) Citizenship or Place United Kingdom
of Organization
- --------------------------------------------------------------------------------
Number of 5) Sole Voting -0-
Shares Beneficially Power
Owned by Each
Reporting Person
With -------------------------------------------------
6) Shared Voting 7,880 shares
Power of Common Stock
-------------------------------------------------
7) Sole Disposi- -0-
tive Power
-------------------------------------------------
8) Shared Dis- 7,880 shares
positive Power of Common Stock
-------------------------------------------------
9) Aggregate Amount Beneficially 7,880 shares
Owned by Each Reporting person of Common Stock
- --------------------------------------------------------------------------------
10) Check if the Aggregate
Amount in Row (9)
Excludes Certain Shares
- --------------------------------------------------------------------------------
11) Percent of Class
Represented by less than 0.1%
Amount in Row (9)
- --------------------------------------------------------------------------------
12) Type of Reporting Person 00
CUSIP No. 60877T 10 1 Page 4 of 5 Pages
AMENDMENT NO. 2 TO SCHEDULE 13G (FINAL AMENDMENT)
Reference is hereby made to the statement on Schedule 13G originally filed
with the Securities and Exchange Commission on January 27, 2005 and Amendment
No. 1 thereto filed on January 26, 2006 (as so amended, the "Schedule 13G".)
Terms defined in the Schedule 13G are used herein as so defined.
The following Items of the Schedule 13G are hereby amended and restated to
read in their entirety as follows:
Item 4 - Ownership.
(a) Amount Beneficially Owned:
MVM Fund No. 1: 1,369,696 shares of Common Stock
MVM : 7,880 shares of Common Stock
(b) Percent of Class:
MVM Fund No. 1: 3.8%
MVM: less than 0.1%
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote: -0-
(ii) shared power to vote or to direct the vote:
MVM Fund No. 1: 1,369,696 shares of Common Stock
MVM: 7,880 shares of Common Stock
(iii) sole power to dispose or to direct the disposition of: -0-
(iv) shared power to dispose or to direct the disposition of:
MVM Fund No. 1: 1,369,696 shares of Common Stock
MVM: 7,880 shares of Common Stock
Item 5 - Ownership Of Five Percent Or Less Of A Class
If this statement is being filed to report the fact that as of the date
hereof the Reporting Persons have ceased to be the beneficial owners of more
than five percent of the Common Stock, check the following: [X]
CUSIP No. 60877T 10 1 Page 5 of 5 Pages
Signature:
After reasonable inquiry and to the best of their knowledge and belief, the
undersigned certify that the information set forth in this statement is true,
complete and correct.
MVM INTERNATIONAL LIFE
SCIENCES FUND NO. 1, L.P.
By /s/ Hugo Harrod
------------------------
Finance Manager
MVM LIFE SCIENCE PARTNERS LLP
By /s/ Hugo Harrod
------------------------
Member
Date: January 25, 2007